{"database": "lobbying", "table": "lobbying_activities", "rows": [[1657928, "01e8c160-621a-426b-866d-287b6a7a6344", "Q1", "POLICY DIRECTIONS INC.", 31747, "ENTERA HEALTH, INC.", 2015, "first_quarter", "MED", "Guidance on Investigational New Drug;\nOverall industry standards", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2015-04-09T15:23:00.087000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1657928"], "units": {}, "query_ms": 0.34440000308677554, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}